[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Orchestra Biomed Hldgs Inc (OBIO)

Orchestra Biomed Hldgs Inc (OBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Orchestra Biomed Hldgs Inc 150 UNION SQUARE DRIVE NEW HOPE PA 18938 USA

https://orchestrabiomed.com Employees: 86 P: 215-862-5797

Sector:

Medical

Description:

Orchestra BioMed Inc. is a biomedical company accelerating high-impact technologies to patients. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy(TM)for the treatment of hypertension and Virtue(R) Sirolimus AngioInfusion(TM) Balloon for the treatment of atherosclerotic artery disease. Orchestra BioMed Inc., formerly known as Health Sciences Acquisitions Corporation 2, is based in NEW HOPE, Pa.

Key Statistics

Overview:

Market Capitalization, $K 234,135
Enterprise Value, $K 223,525
Shares Outstanding, K 59,881
Float, K 55,390
% Float 92.50%
Short Interest, K 842
Short Float 1.41%
Days to Cover 3.21
Short Volume Ratio 0.62
% of Insider Shareholders 7.50%
% of Institutional Shareholders 53.20%

Financials:

Annual Sales, $ 33,480 K
Annual Net Income, $ -52,700 K
Last Quarter Sales, $ 110 K
Last Quarter Net Income, $ -20,690 K
EBIT, $ -54,970 K
EBITDA, $ -54,430 K

Growth:

1-Year Return 39.12%
3-Year Return -75.14%
5-Year Return -61.44%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.33 on 05/12/26
Next Earnings Date 08/11/26
Earnings Per Share ttm -0.97
EPS Growth vs. Prev Qtr -226.92%
EPS Growth vs. Prev Year 32.65%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

OBIO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -157.46%
Return-on-Assets % -60.18%
Profit Margin % -157.41%
Debt/Equity 0.35
Price/Sales 7.12
Price/Cash Flow N/A
Price/Book 5.79
Book Value/Share 0.69
Interest Coverage -0.96
60-Month Beta 0.52
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.